A review of the role of levocetirizine as an effective therapy for allergic disease

Research output: Contribution to journalLiterature review

10 Citations (Scopus)

Abstract

Background: Levocetirizine is the R-enantiomer of cetirizine dihydrochloride with pharmacodynamically and pharmacokinetically favourable characteristics. Objective: To review the evidence that levocetirizine is an effective therapy for allergic disease. Methodology: Relevant articles in English or with English abstracts were identified from systematic PubMed searches. Results: Levocetirizine has high bioavailability, high affinity for and occupancy of the H1 receptor, rapid onset of action, limited distribution and minimal hepatic metabolism. Clinical trials indicate that it is safe and effective for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children with a minimal number of untoward effects. It is also becoming clearer that, in addition to its being a potent antihistamine, levocetirizine has several anti-inflammatory effects that are observed at clinically relevant concentrations that may enhance its therapeutic benefit. Furthermore, there appears to be a growing trend for the use of levocetirizine as long-term therapy in addition to it being used as a treatment for the immediate short-term manifestations of allergic disease. Conclusion: Levocetirizine is an effective and safe treatment for use in adults and children with allergic disease.

Original languageEnglish
Pages (from-to)859-867
Number of pages9
JournalExpert Opinion on Pharmacotherapy
Volume9
Issue number5
DOIs
Publication statusPublished - Apr 2008

Keywords

  • allergy
  • antihistamine
  • anti-inflammatory
  • levocetirizine
  • chronic idiopathic urticaria
  • histamine-induced wheal
  • quality-of-life
  • cell-adhesion molecule-1
  • double-blind
  • healthy-volunteers
  • nasal obstruction
  • flare response
  • human skin
  • rhinitis

Cite this

A review of the role of levocetirizine as an effective therapy for allergic disease. / Walsh, Garry M.

In: Expert Opinion on Pharmacotherapy, Vol. 9, No. 5, 04.2008, p. 859-867.

Research output: Contribution to journalLiterature review

@article{d3551d5b1cfa4ba8acd50aab3e84c3cf,
title = "A review of the role of levocetirizine as an effective therapy for allergic disease",
abstract = "Background: Levocetirizine is the R-enantiomer of cetirizine dihydrochloride with pharmacodynamically and pharmacokinetically favourable characteristics. Objective: To review the evidence that levocetirizine is an effective therapy for allergic disease. Methodology: Relevant articles in English or with English abstracts were identified from systematic PubMed searches. Results: Levocetirizine has high bioavailability, high affinity for and occupancy of the H1 receptor, rapid onset of action, limited distribution and minimal hepatic metabolism. Clinical trials indicate that it is safe and effective for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children with a minimal number of untoward effects. It is also becoming clearer that, in addition to its being a potent antihistamine, levocetirizine has several anti-inflammatory effects that are observed at clinically relevant concentrations that may enhance its therapeutic benefit. Furthermore, there appears to be a growing trend for the use of levocetirizine as long-term therapy in addition to it being used as a treatment for the immediate short-term manifestations of allergic disease. Conclusion: Levocetirizine is an effective and safe treatment for use in adults and children with allergic disease.",
keywords = "allergy, antihistamine, anti-inflammatory, levocetirizine, chronic idiopathic urticaria, histamine-induced wheal, quality-of-life, cell-adhesion molecule-1, double-blind, healthy-volunteers, nasal obstruction, flare response, human skin, rhinitis",
author = "Walsh, {Garry M.}",
year = "2008",
month = "4",
doi = "10.1517/14656566.9.5.859",
language = "English",
volume = "9",
pages = "859--867",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - A review of the role of levocetirizine as an effective therapy for allergic disease

AU - Walsh, Garry M.

PY - 2008/4

Y1 - 2008/4

N2 - Background: Levocetirizine is the R-enantiomer of cetirizine dihydrochloride with pharmacodynamically and pharmacokinetically favourable characteristics. Objective: To review the evidence that levocetirizine is an effective therapy for allergic disease. Methodology: Relevant articles in English or with English abstracts were identified from systematic PubMed searches. Results: Levocetirizine has high bioavailability, high affinity for and occupancy of the H1 receptor, rapid onset of action, limited distribution and minimal hepatic metabolism. Clinical trials indicate that it is safe and effective for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children with a minimal number of untoward effects. It is also becoming clearer that, in addition to its being a potent antihistamine, levocetirizine has several anti-inflammatory effects that are observed at clinically relevant concentrations that may enhance its therapeutic benefit. Furthermore, there appears to be a growing trend for the use of levocetirizine as long-term therapy in addition to it being used as a treatment for the immediate short-term manifestations of allergic disease. Conclusion: Levocetirizine is an effective and safe treatment for use in adults and children with allergic disease.

AB - Background: Levocetirizine is the R-enantiomer of cetirizine dihydrochloride with pharmacodynamically and pharmacokinetically favourable characteristics. Objective: To review the evidence that levocetirizine is an effective therapy for allergic disease. Methodology: Relevant articles in English or with English abstracts were identified from systematic PubMed searches. Results: Levocetirizine has high bioavailability, high affinity for and occupancy of the H1 receptor, rapid onset of action, limited distribution and minimal hepatic metabolism. Clinical trials indicate that it is safe and effective for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children with a minimal number of untoward effects. It is also becoming clearer that, in addition to its being a potent antihistamine, levocetirizine has several anti-inflammatory effects that are observed at clinically relevant concentrations that may enhance its therapeutic benefit. Furthermore, there appears to be a growing trend for the use of levocetirizine as long-term therapy in addition to it being used as a treatment for the immediate short-term manifestations of allergic disease. Conclusion: Levocetirizine is an effective and safe treatment for use in adults and children with allergic disease.

KW - allergy

KW - antihistamine

KW - anti-inflammatory

KW - levocetirizine

KW - chronic idiopathic urticaria

KW - histamine-induced wheal

KW - quality-of-life

KW - cell-adhesion molecule-1

KW - double-blind

KW - healthy-volunteers

KW - nasal obstruction

KW - flare response

KW - human skin

KW - rhinitis

U2 - 10.1517/14656566.9.5.859

DO - 10.1517/14656566.9.5.859

M3 - Literature review

VL - 9

SP - 859

EP - 867

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 5

ER -